<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Summary of the vaccine development tool bottlenecks. These bottlenecks identify generic rate-limiting stages in vaccine development that could be alleviated through further research spending, changes in policy of investment into infrastructure.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Stage in development</th>
    <th>Short description</th>
    <th>Type of bottleneck</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Pre-clinical discovery</td>
    <td>
     <list list-type="simple" id="l0005">
      <list-item id="o0005">
       <label>•</label>
       <p id="p0005">Pathogen biology including
        <list list-type="simple" id="l0010">
         <list-item id="o0010">
          <label>-</label>
          <p id="p0010">Human-host immunology</p>
         </list-item>
         <list-item id="o0015">
          <label>-</label>
          <p id="p0015">Pathogen Challenge model</p>
         </list-item>
        </list>
       </p>
      </list-item>
      <list-item id="o0020">
       <label>•</label>
       <p id="p0020">Freedom to operate</p>
      </list-item>
     </list>
    </td>
    <td>
     <list list-type="simple" id="l0015">
      <list-item id="o0025">
       <label>•</label>
       <p id="p0025">Research</p>
      </list-item>
      <list-item id="o0030">
       <label>•</label>
       <p id="p0030">Policy</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td colspan="3">  </td>
   </tr>
   <tr>
    <td>Pre-clinical development</td>
    <td>
     <list list-type="simple" id="l0020">
      <list-item id="o0035">
       <label>•</label>
       <p id="p0035">Process development including,
        <list list-type="simple" id="l0025">
         <list-item id="o0040">
          <label>-</label>
          <p id="p0040">Critical process parameters</p>
         </list-item>
         <list-item id="o0045">
          <label>-</label>
          <p id="p0045">Critical quality attributes</p>
         </list-item>
         <list-item id="o0050">
          <label>-</label>
          <p id="p0050">Adjuvants and formulation</p>
         </list-item>
        </list>
       </p>
      </list-item>
      <list-item id="o0055">
       <label>•</label>
       <p id="p0055">Animal model choice</p>
      </list-item>
      <list-item id="o0060">
       <label>•</label>
       <p id="p0060">Scale-up and clinical manufacture
        <list list-type="simple" id="l0030">
         <list-item id="o0065">
          <label>-</label>
          <p id="p0065">GMP bulk</p>
         </list-item>
         <list-item id="o0070">
          <label>-</label>
          <p id="p0070">GMP fill-finish</p>
         </list-item>
        </list>
       </p>
      </list-item>
     </list>
    </td>
    <td>
     <list list-type="simple" id="l0035">
      <list-item id="o0075">
       <label>•</label>
       <p id="p0075">Research</p>
      </list-item>
      <list-item id="o0080">
       <label>•</label>
       <p id="p0080">Research</p>
      </list-item>
      <list-item id="o0085">
       <label>•</label>
       <p id="p0085">Infrastructure</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td colspan="3">  </td>
   </tr>
   <tr>
    <td>Clinical development</td>
    <td>
     <list list-type="simple" id="l0040">
      <list-item id="o0090">
       <label>•</label>
       <p id="p0090">GMO regulation</p>
      </list-item>
      <list-item id="o0095">
       <label>•</label>
       <p id="p0095">Trial sites and NRA approval</p>
      </list-item>
      <list-item id="o0100">
       <label>•</label>
       <p id="p0100">Regulatory and ethical approval</p>
      </list-item>
     </list>
    </td>
    <td>
     <list list-type="simple" id="l0045">
      <list-item id="o0105">
       <label>•</label>
       <p id="p0105">Policy</p>
      </list-item>
     </list>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
